Anavex Life Sciences Corp (AVXL)

[B60611]

Good stuff! It defies belief that they would invest this much money (and 50% of an appropriately powered / 48+ week trial is going to be a significant figure) without knowing something and / or immediately preceding disappointing PDD results. In a non-manipulated market that 50% would be estimated and appropriately added to the MC. I figured it should be at least a 15% bump to SP just due to its effect on preventing further dilution over the next 18-24 mos. I don’t necessarily expect the SP bump, as I think we’re solely waiting for PDD results at this point, but this bit of info is a serious crumb / dot / warning by Herr Missling.

Planning to initiate (with considerable help) a general PD trial is huge news imo, and if the PDD results are positive, the implication of a much larger PD patient universe also taking the drug will supersize the company’s bottom line.